Publications by authors named "Takahiro Kogawa"

39Publications

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer.

Case Rep Oncol Med 2020 16;2020:7231358. Epub 2020 Jun 16.

Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2020/7231358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317333PMC
June 2020

Cisplatin and S-1 for urachal carcinoma: A single-institution case series.

IJU Case Rep 2019 May 9;2(3):150-154. Epub 2019 Apr 9.

Department of Breast and Medical Oncology National Cancer Center Hospital East Chiba Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/iju5.12066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292134PMC
May 2019

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.

Breast Cancer Res Treat 2018 Sep 18;171(2):501-511. Epub 2018 Jun 18.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4853-4DOI Listing
September 2018

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes.

Oncotarget 2017 Sep 31;8(41):70481-70495. Epub 2017 Jul 31.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/19719
Publisher Site
http://dx.doi.org/10.18632/oncotarget.19719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642571PMC
September 2017

Thrombocytosis as a prognostic factor in inflammatory breast cancer.

Breast Cancer Res Treat 2017 Dec 22;166(3):819-832. Epub 2017 Aug 22.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1220 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4463-6
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4463-6DOI Listing
December 2017

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.

Clin Cancer Res 2017 Aug 2;23(16):4780-4792. Epub 2017 May 2.

Section of Translational Breast Cancer Research, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559319PMC
August 2017

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy.

Br J Cancer 2017 Feb 12;116(4):509-514. Epub 2017 Jan 12.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318977PMC
February 2017

A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors.

Invest New Drugs 2017 06 4;35(3):307-314. Epub 2017 Jan 4.

Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa City, Chiba Prefecture, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-016-0422-z
Publisher Site
http://dx.doi.org/10.1007/s10637-016-0422-zDOI Listing
June 2017

High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.

Oncologist 2016 Jan 9;21(1):21-7. Epub 2015 Dec 9.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709200PMC
January 2016

Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.

Clin Breast Cancer 2015 Feb 15;15(1):37-42. Epub 2014 Aug 15.

Department of Breast Medical Oncology, The University Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2014.06.007DOI Listing
February 2015

The role of inflammation in inflammatory breast cancer.

Adv Exp Med Biol 2014 ;816:53-73

Department of Breast Medical Oncology, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-0348-0837-8_3DOI Listing
September 2014

[Evaluation of skin toxicity caused by cetuximab related to its clinical response].

Gan To Kagaku Ryoho 2012 Aug;39(8):1221-5

Division of Medical Oncology, KKR Sapporo Medical Center, Japan.

View Article

Download full-text PDF

Source
August 2012

[Summary of informed consent on chemotherapy to colorectal cancer patients].

Nihon Rinsho 2011 Apr;69 Suppl 3:618-21

Division of Medical Oncology, KKR Sapporo Medical Center Tonan Hospital.

View Article

Download full-text PDF

Source
April 2011

[Anti-epidermal growth factor receptor monoclonal antibodies induced adverse events].

Gan To Kagaku Ryoho 2010 May;37(5):787-90

Department of Medical Oncology, KKR Sapporo Medical Center Tonan Hospital, Chuo-ku, Sapporo, Japan.

View Article

Download full-text PDF

Source
May 2010

A retroperitoneal sympathetic paraganglioma invading the duodenum and mimicking a submucosal tumor.

Endocr Pathol 2008 ;19(2):128-32

Department of Pathology, Hakodate Hospital, Japan National Hospital Organization, 16-18 Kawahara, Hakodate, Hokkaido, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12022-008-9025-3DOI Listing
October 2008

Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.

Clin Gastroenterol Hepatol 2005 Jul;3(7 Suppl 1):S42-5

Sapporo Medical University School of Medicine, 4th Department of Internal Medicine, Hokkaido, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1542-3565(05)00257-0DOI Listing
July 2005

Chemoprevention of colorectal cancer.

Cancer Chemother Pharmacol 2004 Sep;54 Suppl 1:S40-3

4th Department of Internal Medicine, Sapporo Medical University School of Medicine, South 1 West 16, Chuo-ku, 060-8543 Sapporo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0885-zDOI Listing
September 2004